All In Biotech

Free tool

FAERS Monitor: Remeron Soltab

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021208 or its brand name (Remeron Soltab, Mirtazapine). Reports on generic versions are filed under their own applications.

Reports

76,416

Serious

66,432

87% of reports

Hospitalization

31,878

Death reported

12,226

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • fatigue4,001
  • nausea3,967
  • drug ineffective3,857
  • toxicity to various agents3,802
  • fall3,461
  • off label use3,442
  • diarrhoea3,394
  • drug interaction3,117
  • dizziness2,985
  • death2,898
  • dyspnoea2,852
  • anxiety2,759
  • vomiting2,709
  • somnolence2,600
  • confusional state2,590

Reports by year received

View as table
YearReports
2004547
2005730
2006808
2007882
2008957
20091,143
20101,379
20111,836
20121,913
20131,817
20142,304
20152,879
20163,351
20173,947
20185,569
20196,224
20206,278
20215,491
20225,684
20235,871
20245,817
20256,213
20264,774

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,977,743 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
toxicity to various agentsSignal3,8026.36.116,792
drug interactionSignal3,1175.55.311,321
confusional stateSignal2,5904.54.36,908
somnolenceSignal2,6003.63.54,833
fallSignal3,4612.92.84,274
anxietySignal2,7592.72.62,926
dizziness2,9851.71.6780
vomiting2,7091.61.5601
diarrhoea3,3941.41.4485
fatigue4,0011.41.4506
dyspnoea2,8521.41.3317
nausea3,9671.41.3432
off label use3,4421.11.022
death2,8980.90.918
drug ineffective3,8570.80.8194

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.